Novo Nordisk A/S (NVO)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
4/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)43%
Our last 30 days of resolved calls came true 29% of the time.See the track record →
Price
$41.71
1 day
-1.93%
1 week
-4.50%
1 month
-5.64%
1 year
-20.24%
Market cap
$1.2T
Company fundamentals
P/E (TTM)
10.7×
EPS (TTM)
$26.18
Debt / Equity
0.63
Current ratio
0.87
Operating margin
43.1%
Net margin
35.4%
Gross margin
80.7%
Return on equity
59.1%
Revenue growth (YoY)
5.6%
Dividend yield
1.00%
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
Example trade plan · illustrative risk framework
Entry zone
$41.08–$42.54
Stop-loss (exit)
$37.54 −10%
Target (exit)
$50.05 +20%
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
Why it ranks: factor attribution
- QualityStrong net margin (35%)+4
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →